ADMA Biologics ADMA

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.79 (-3.57%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

ADMA Biologics (ADMA) Business Model and Operations Summary
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Key Insights

ADMA Biologics (ADMA) Core Market Data and Business Metrics
  • Latest Closing Price

    $21.23
  • Market Cap

    $5.08 Billion
  • Total Outstanding Shares

    237.62 Million Shares
  • Total Employees

    685
  • Dividend

    No dividend
  • IPO Date

    October 17, 2013
  • SIC Description

    Biological Products, (no Disgnostic Substances)
  • Primary Exchange

    NASDAQ
  • Headquarters

    C/o Adma Biologics, Inc., Ramsey, NJ, 07446

Historical Stock Splits

Execution DateSplit Amount

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ADMA from trusted financial sources

    Related Companies

    Publicly traded companies similar to ADMA Biologics (ADMA)